For PA, with the exception of the small proportion of patients with familial hyperaldosteronism type I, the underlying genetic and molecular basis of the disease remains largely unknown, particularly the role of aldosterone synthase in the pathogenic mechanism of primary aldosteronism-related hypertension is currently not quite clear. Here, CYP11B2 is linked to hypertensive disorder.